John Librie

John is a seasoned executive with more than 30 years of experience in the biopharmaceutical/medical technology industry, where he has held senior executive positions. He was the CEO of ONY Biotech and the CEO of Shore Therapeutics. In addition, he drove the early commercialization of Cenentech and Acorda Therapeutics. In each of his previous roles. John's integral participation resulted in the company's successful growth.